Indeed, HSF1 is well-known to be activated in cancer cells of various tumor types112, and may be mediating a pro-tumorigenic feedback loop between cancer cells and CAFs in BRCA2-deficient tumors. This evidence concerns the gene BRCA2 and neoplasm.